CIC
ALXO icon

Cornercap Investment Counsel’s ALX Oncology ALXO Stock Holding History

Cornercap Investment Counsel’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,292
Closed -$62.1K – 523
2024
Q2 		$62.1K Sell
10,292
-148
-1% -$1.82K 0.01% 578
2024
Q1 		$116K Buy
+10,440
New +$147K 0.02% 583
2023
Q4 		– Sell
-35,071
Closed -$168K – 583
2023
Q3 		$168K Buy
35,071
+2,288
+7% +$12.4K 0.03% 501
2023
Q2 		$246K Buy
+32,783
New +$215K 0.04% 484

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cornercap Investment Counsel's ALXO Position: Q3 2024 in Review

Cornercap Investment Counsel sold out of ALX Oncology (ALXO) in Q3 2024, closing a stake of 10,292 shares — an estimated $62.1K sold.

Cornercap Investment Counsel first reported a position in ALXO in Q2 2023 and held it in 4 quarters. The position peaked at $246K in Q2 2023. 92 funds tracked by Wall St. Rank hold ALXO as of Q3 2024.

  • Cornercap Investment Counsel reported no remaining ALX Oncology position as of Q3 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 10,292 ALX Oncology shares in Q3 2024, an estimated $62.1K.
  • Cornercap Investment Counsel first reported a position in ALX Oncology in Q2 2023 and held it in 4 quarters.
  • Cornercap Investment Counsel's ALX Oncology position peaked at $246K in Q2 2023.
  • 92 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2024.

Based on Cornercap Investment Counsel's 13F filing for Q3 2024, filed 6 Nov 2024.